Maier

Comerica Bank Announces Details on New Investment Banking Group

Retrieved on: 
Wednesday, February 1, 2023

DALLAS, Feb. 1, 2023 /PRNewswire/ -- Comerica Securities, a subsidiary of Comerica Bank , has formed a new Investment Banking Group.

Key Points: 
  • DALLAS, Feb. 1, 2023 /PRNewswire/ -- Comerica Securities, a subsidiary of Comerica Bank , has formed a new Investment Banking Group.
  • Jeff Wilson, Managing Director, Investment Banking: Wilson joined Comerica in September 2022 after serving as Managing Director for American Industrial Acquisition Corporation.
  • Comerica Bank is a subsidiary of Comerica Incorporated (NYSE: CMA), a financial services company headquartered in Dallas, Texas, and strategically aligned by three business segments: The Commercial Bank, The Retail Bank and Wealth Management.
  • Services are offered through Comerica Securities, Inc., which is a broker/dealer, federally Registered Investment Advisor, member FINRA/SIPC and subsidiary of Comerica Bank.

Calabrio Welcomes SaaS Experts Daniel Maier and Ryan Toben to Further Develop Revenue Acquisition and Customer Success Initiatives

Retrieved on: 
Tuesday, October 25, 2022

Calabrio , the workforce performance company, has hired Daniel Maier as chief revenue officer and Ryan Toben as senior vice president of customer success and sales operations.

Key Points: 
  • Calabrio , the workforce performance company, has hired Daniel Maier as chief revenue officer and Ryan Toben as senior vice president of customer success and sales operations.
  • Both individuals have extensive business development, revenue generation, and customer success experience from previous leadership positions at top SaaS (Software as a Service) brands.
  • He is tasked with driving overall revenue at Calabrio, including leading the sales function which now encompasses customer success programs.
  • Prior to Calabrio, he was at Gainsight, a leading customer success, product experience, and community engagement solution vendor.

T. HASEGAWA USA SUPPORTS GROWTH OF R&D TEAM WITH NEW DIRECTOR OF SAVORY TECHNOLOGY

Retrieved on: 
Thursday, August 11, 2022

CERRITOS, Calif., Aug. 11, 2022 /PRNewswire/ -- The U.S. subsidiary of one of the world's top flavor companies is expanding its expertise in food and beverage flavor development through the addition of a principal flavorist leveraging more than three decades of industry experience.

Key Points: 
  • Today, T. Hasegawa USA, Inc. announces Mary Maier has joined the company as director of savory technology, where she will oversee the development of food flavors, refine reaction flavor processes and boost production.
  • Maier will serve in the role that was previously held by former Director of Savory Technology, Louise Bone, who retired from T. Hasegawa in 2021.
  • "We are thrilled to welcome Mary to our team, and we'll greatly benefit from her extensive industry experience," said Tom Damiano, CEO of T. Hasegawa USA.
  • "We have invested heavily in R&D over the past few years, to build a world-class team and introduce new technology that expands our flavor development capabilities.

CalAmp Board of Directors Elects Henry Maier as Next Independent Chair

Retrieved on: 
Tuesday, May 17, 2022

Maier will succeed Amal Johnson, who has served as Chair of the Board since August 2020 and, as previously announced, will not stand for re-election at the upcoming Annual Meeting.

Key Points: 
  • Maier will succeed Amal Johnson, who has served as Chair of the Board since August 2020 and, as previously announced, will not stand for re-election at the upcoming Annual Meeting.
  • Maier joined the CalAmp Board in June 2021 and serves on the Boards Audit Committee and Human Capital Committee.
  • As CalAmp executes on its strategy to meet the growing demand for telematics solutions, the Board and I are confident that Henry is the right leader to guide our continued growth and innovation as Chair.
  • CalAmps mission to transform the global connected economy is more critical than ever, and I am honored to further serve the Company as Chair of the Board, said Henry Maier.

 4D Pharma Appointments Paul Maier to the Board as Non-Executive Director

Retrieved on: 
Monday, March 1, 2021

Previous directorships held in the past five years:

Key Points: 
  • Previous directorships held in the past five years:
    Paul Maier does not currently hold any ordinary shares in the Company.
  • Save as set out above there are no further disclosures pursuant to Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies in respect of the appointment of Paul Maier.
  • 4D has developed a proprietary platform, MicroRx, that rationally identifies Live Biotherapeutics based on a deep understanding of function and mechanism.
  • 4D pharma's Live Biotherapeutic products (LBPs) are orally delivered single strains of bacteria that are naturally found in the healthy human gut.